GlassScriptPhysician profile
Mitchell Scott Mcclure
NPI 1770764128
$5,543.91
in general payments reported to CMS, 2019-2025
40 companies · $677 in 2025
The $677 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $178 · 2021: $427 · 2022: $1,010 · 2023: $1,398 · 2024: $1,257 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,332.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $905.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $648.29 | 2021-2025 | |
| Lilly USA, LLC | $610.66 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $543.97 | 2019-2025 | |
| Abbott Laboratories | $442.83 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $340.12 | 2019-2024 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $309.52 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $279.39 | 2022-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.99 | 2023-2024 | Synjardy, Tradjenta, Jardiance |
| Novartis Pharmaceuticals Corporation | $130.55 | 2019-2022 | |
| Dexcom, INC. | $117.84 | 2021-2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.11 | 2019-2023 | Xifaxan |
| Exact Sciences Corporation | $102.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $76.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.39 | 2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.